publication date: Mar 8, 2012
|
author/source: bcsAgency
Clinical
Reference Laboratory (CRL), a global leader in the provision of central laboratory
services for the clinical trials industry, has today announced the full
integration of its long-standing laboratory partner Phoenix Pharma Central
Services in Singapore.
The
integration of Phoenix's testing platforms into
CRL's proprietary Global LIMSystem enhances CRL's support of clinical trials in
Asia through improved efficiencies, increased
quality, reduced costs and full global project oversight. In addition it
further builds on Phoenix's
experienced management team, a profound knowledge of the Asian market and
extensive domain knowledge in clinical trials.
Tim
Sotos, chief executive officer of CRL, said: "We have a trusted relationship
with Phoenix,
having worked together for over a decade supporting a large number of clinical
trials globally.
"By
incorporating Phoenix's data into our centralized Global LIMSystem it allows
for both sites and clinical teams to access their data throughout the world
using CRL's proprietary web-based ‘OASIS' systems. This provides drug
development companies with direct oversight on the status of their trial and
allows them to evaluate drug safety on a real-time basis."
Through
CRL's globally implemented IT system, every clinical trial sample drawn
anywhere in the world will immediately be entered into its LIMSystem to assure
real time global tracking of any specimen.
Dr.
Yan Lee, chief executive officer at Phoenix Pharma Central Services, said: "We
have enjoyed a successful business relationship with CRL for a number of years
and for the company to integrate us into their IT system shows a real
commitment to both Phoenix
and the industry. Together we are well positioned to provide support to
pharmaceutical and biotechnological industries in the development of drugs and
medical devices. "
CRL
is one of the largest privately-held laboratories in the USA offering central laboratory
services for the support of clinical trials to the global pharmaceutical and
biotechnology industry. It also has a wholly-owned CAP-accredited European
operation in Cambridge, UK and has a proven track record in
providing complete central laboratory solutions to support more than 4,000
clinical trials across the globe.
Tim
Sotos added: "We are implementing a network of laboratories to deliver us with
full global oversight of clinical trials worldwide. The partnership also means
our clients will receive the utmost local experience working with laboratories
in every continent. Importantly the innovative execution of a sound business
model allows us to fully streamline our global operations."
For
further information about CRL and its worldwide network of laboratories, visit
the website at
www.crlcorp.com.
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.